Literature DB >> 6705387

Erdheim-Chester disease. A case report.

G G Poehling, D M Adair, H A Haupt.   

Abstract

In a 57-year-old woman dizziness, staggering, altered mental status, and bilateral pain and cramping in the lower extremities developed. Extensive investigation yielded evidence of renal and long-bone lesions, with the latter being primarily metaphyseal and diaphyseal. Needle biopsy of the tibial marrow revealed the presence of lipid-laden histiocytes, osteosclerosis, and osteoclasts. A diagnosis of Erdheim-Chester disease was made; this is the 16th known case of the disease. The patient responded well to steroid therapy but later was readmitted and ultimately died of extensive infiltrates in the kidneys and pancreas. Erdheim-Chester disease, an extremely rare multisystem histiocytic disorder, has been characterized as a lipid (cholesterol) granulomatosis. Renal, cardiac, and pulmonary involvement are noted in most cases; the roentgenographic signs of skeletal involvement, when present, are pathognomonic.

Entities:  

Mesh:

Year:  1984        PMID: 6705387

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

Review 1.  Scintigraphic findings and follow up in Erdheim-Chester disease.

Authors:  D Sandrock; M J Merino; B H Scheffknecht; R D Neumann
Journal:  Eur J Nucl Med       Date:  1990

Review 2.  Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature.

Authors:  Florence Lachenal; François Cotton; Hélène Desmurs-Clavel; Julien Haroche; Hervé Taillia; Nadine Magy; Mohamed Hamidou; Juan Salvatierra; Jean-Charles Piette; Denis Vital-Durand; Hugues Rousset
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

Review 3.  Pancreatic involvement in Erdheim-Chester disease: a case report and review of the literature.

Authors:  Jia-Wen Dai; Tian-Hua He; Ming-Hui Duan; Yue Li; Xin-Xin Cao
Journal:  BMC Gastroenterol       Date:  2022-06-21       Impact factor: 2.847

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.